RICHARD A. VAN DEN BROEK

Corporate Board Profile

Tech Score: 0/100

Celldex Therapeutics, Inc.

Filing Date	Source Excerpt
2015-04-23	Richard A. van den Broek has been a director of Celldex since December 2014. The Compensation Committee currently consists of Karen L. Shoos, Chair, George O. Elston, Harry H. Penner, Jr. and Richard van den Broek. The Nominating and Corporate Governance Committee currently consists of Herbert J. Conrad, Chair, Karen L. Shoos and Richard van den Broek. The following table summarizes the annual compensation for our non- employee directors during 2014. Richard van den Broek Fees Earned or Paid in Cash $18,500 Stock Awards $36,210 Option Awards $91,480 Total $146,190.
2016-04-21	Richard A. van den Broek Age 50 Year First Became Director 2014. Mr. van den Broek is member of the Compensation and Nominating Committees. Director Compensation Table shows total compensation $415,975.

Filing Date

Source Excerpt

2015-04-23

Richard A. van den Broek has been a director of Celldex since December 2014. The Compensation Committee currently consists of Karen L. Shoos, Chair, George O. Elston, Harry H. Penner, Jr. and Richard van den Broek. The Nominating and Corporate Governance Committee currently consists of Herbert J. Conrad, Chair, Karen L. Shoos and Richard van den Broek. The following table summarizes the annual compensation for our non- employee directors during 2014. Richard van den Broek Fees Earned or Paid in Cash $18,500 Stock Awards $36,210 Option Awards $91,480 Total $146,190.

2016-04-21

Richard A. van den Broek Age 50 Year First Became Director 2014. Mr. van den Broek is member of the Compensation and Nominating Committees. Director Compensation Table shows total compensation $415,975.

Data sourced from SEC filings. Last updated: 2025-08-30